Drug recall · April 17, 2024
Isotretinoin Capsules recall
Why: Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15
- Lots / codes
Lot #: 100044259, Exp 06/30/2025.
- Quantity
- 5,304 3x10-cartons
- Company
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 28, 2024 · Voluntary: Firm initiated
- Classified
- April 8, 2024
- Reported
- April 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Isotretinoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.